Table 2.
HIV-Related Characteristics
| Parameter | Men | Women | P Value |
|---|---|---|---|
| CD4 cell count, median (range), 106/L | 645 (285–1390) |
644 (222–1780) | .45 |
| CD4 cell count >350 106/L, No. (%) | 47 (94) | 42 (95) | .60 |
| Nadir CD4 cell count, median (range), 106/L | 157 (0–606) | 156 (3–553) | .78 |
| HIV RNA, median (range), copies/mL | 19 (19–39) | 19 (19–36) | .71 |
| HIV RNA ≤20 copies/mL, No. (%) | 47 (94) | 41 (93) | .59 |
| HIV duration, mean ± SEM, y | 16.5 ± 1 | 14.4 ± 1 | .13 |
| ART duration, mean ± SEM, y | 12.6 ± 0.6 | 11.2 ± 0.7 | .13 |
| ART regimens, No. (%) | |||
| ≥2 NRTIs + ≥1 NNRTI | 31 (62) | 24 (55) | .31 |
| ≥2 NRTIs + PI | 13 (26) | 11 (25) | .55 |
| PI only | 3 (6) | 1 (2) | .36 |
| INI | 2 (4) | 6 (14) | .09 |
| Other | 1 (2) | 2 (5) | .54 |
Abbreviations: ART, antiretroviral treatment; INI, integrase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; SEM, standard error of the mean.